Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 17 Apr 2024

Development and validation of a nomogram to predict medication risk based on a knowledge, attitude and practice (KAP) survey of residents in Shanxi Province, China

in Drugs Outcomes Research and Policies

Da-shuai Xie
Xue-hu Xie
Li-hua Yang
Na Li
Xiao Zhang
Yi-tong Xie
Wei Yang
Yao-jun Ning
Jun Xie
Xiao-jun Cheng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302274

4,550 views
1 citation

Original Research

Published on 17 Apr 2024

Developing practical recommendations for drug-disease interactions in patients with hypertension

in Drugs Outcomes Research and Policies

Kübra Özokcu
Maaike M. E. Diesveld
Suzan G. H. Gipmans
Laura E. J. Peeters
Bert-Jan van den Born
Sander D. Borgsteede

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1360146

2,179 views
1 citation

Original Research

Published on 11 Apr 2024

Availability, pricing, and affordability of essential medicines for pediatric population in Malawi

in Drugs Outcomes Research and Policies

Francis Kachidza Chiumia
Cynthia Chithope-Mwale
Felix Abikoloni
Vanessa Matchaya
Tadala Gaviyawo
Felix Khuluza

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379250

2,793 views
1 citation

Original Research

Published on 11 Apr 2024

The Simplified Medication Adherence Questionnaire: validation of a Brazilian-Portuguese version in hypertensive adults

in Drugs Outcomes Research and Policies

Simony M. Soares
Mirela Q. de Almeida Diniz
Dilcy Morgana B. M. C. Davino
Fernanda B. Albieri
Adriano S. Santos
Elisdete M. S. Jesus
Divaldo P. Lyra-Junior
Sabrina J. Neves
Alfredo D. Oliveira-Filho

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348917

3,573 views
1 citation

Original Research

Published on 10 Apr 2024

Access to a tailored mobile application enhances medication adherence among young users of antidepressants

in Drugs Outcomes Research and Policies

Rønnaug Eline Larsen
Kristine Hole
Maria Lie Selle
Cecilie Johannessen Landmark
Tonje Krogstad
Lene Berge Holm

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1379700

1,458 views

Original Research

Published on 10 Apr 2024

Implementing the EU HTA regulation: Insights from semi-structured interviews on patient expectations, Belgian and European institutional perspectives, and industry outlooks

in Drugs Outcomes Research and Policies

Thomas Desmet
Maud Brijs
Frank Vanderdonck
Sven Tops
Steven Simoens
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369508

5,007 views
6 citations

Original Research

Published on 09 Apr 2024

Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland

in Drugs Outcomes Research and Policies

Przemysław Kardas
Angelika Kwiatek
Piotr Włodarczyk
Filip Urbański
Beata Ciabiada-Bryła

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1350717

1,331 views
1 citation

Original Research

Published on 09 Apr 2024

Temporal characteristics and associated factors of discontinuation and outcomes after percutaneous coronary intervention

in Drugs Outcomes Research and Policies

Haiyan Xu
Wanxiang Zheng
Jiangqin Tan
Min Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355231

780 views

General Commentary

Published on 09 Apr 2024

Response: Commentary: Quantile treatment effect of zinc lozenges on common cold duration: a novel approach to analyze the effect of treatment on illness duration

in Drugs Outcomes Research and Policies

Harri Hemilä
Elizabeth Chalker
Janne Tukiainen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1335784

792 views
2 citations

Original Research

Published on 02 Apr 2024

Real-world evidence of the effects of sodium-glucose co-transporter 2 inhibitors on the dosing of diuretics in patients with heart failure: a retrospective cohort study

in Drugs Outcomes Research and Policies

Abdulaziz Alsalem
Mohammed M. Alsultan
Faisal Alqarni
Abdullah Almangour
Lolwa Alsharekh
Saleem Alenazi
Saleh Alzahrani
Raghad A. Almanqour
Abdullah Alazmi
Abdullah Alzahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366439

2,007 views
1 citation

Original Research

Published on 02 Apr 2024

Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland

in Drugs Outcomes Research and Policies

Claire Coumau
Frederic Gaspar
Jean Terrier
Angela Schulthess-Lisibach
Monika Lutters
Marie-Annick Le Pogam
Chantal Csajka

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1332147

2,365 views
4 citations

Original Research

Published on 28 Mar 2024

Osimertinib in the treatment of resected EGFR-mutated non-small cell lung cancer: a cost-effectiveness analysis in the United States

in Drugs Outcomes Research and Policies

Gengwei Huo
Ying Song
Wenjie Liu
Xuchen Cao
Peng Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1300183

2,866 views
1 citation

Review

Published on 28 Mar 2024

Dose reduction of biologics in patients with plaque psoriasis: a review

in Drugs Outcomes Research and Policies

C. A. M. van Riel
C. A. J. Michielsens
M. E. van Muijen
L. S. van der Schoot
J. M. P. A. van den Reek
E. M. G. J. de Jong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369805

3,677 views
5 citations

Clinical Trial

Published on 28 Mar 2024

Effectiveness of pharmacist-led medication reconciliation on medication errors at hospital discharge and healthcare utilization in the next 30 days: a pragmatic clinical trial

in Drugs Outcomes Research and Policies

Maja Jošt
Mojca Kerec Kos
Mitja Kos
Lea Knez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377781

5,058 views
5 citations

Original Research

Published on 27 Mar 2024

Patient experience of medication administration and development of a Patient Experience and Preference Questionnaire (PEPQ) for patients with advanced or metastatic cancer

in Drugs Outcomes Research and Policies

Anne Skalicky
Bryan Bennett
Judith Raimbourg
Sara Lonardi
Julia Correll
Iwona Lugowska
Matthew Dixon
Nashmel Sargalo
Mona L. Martin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1310546

2,570 views
1 citation

Original Research

Published on 26 Mar 2024

Cost-effectiveness of immune checkpoint inhibitors in treating metastatic urothelial cancer

in Drugs Outcomes Research and Policies

Li-Yu Yang
Jian-Ri Li
Chuan-Shu Chen
Chen-Li Cheng
Sheng-Chun Hung
Kun-Yuan Chiu
Cheng-Kuang Yang
Chiann-Yi Hsu
Shian-Shiang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1281654

1,727 views